HOME > BUSINESS > NIV to help Sun Pharma test Zika, Dengue and Chikungunya drugs

NIV to help Sun Pharma test Zika, Dengue and Chikungunya drugs

Sun Pharma announced a tie-up with National Institute of Virology (NIV) under the Indian Council of Medical Research for testing various compounds for treating rapidly spreading viral infections — Zika, Chikungunya and Dengue.

The compounds will include those sourced from plants, animals and chemical entities developed by Sun Pharma. NIV will do the testing against Zika, Chikungunya and Dengue.

Candidate molecules with encouraging data will then be taken forward for commercial development.

“Sun Pharma and NIV aim to promote discovery sciences, translational health research and development of medical products, which is in sync with the direction provided by Govt. of India’s ‘Make In India’ initiative,” the company said.

The agreement follows a similar tie-up with the Indian Council of Medical Research (ICMR) for conducting joint scientific research and innovation for testing of drugs, biosimilars and vaccines and disease control and elimination programs.

“Together, Sun Pharma and NIV will work together to respond to significant and emerging public health threats in India and rest of the world due to viruses: Zika, Chikungunya and Dengue.”

India has seen an explosion of cases of such viral infections, particularly Dengue and Chikungunya. These spread faster in the early days of the rainy season as water collects in empty vessels, bottles, tires and other articles, providing a ready breeding ground for Aedes mosquito.

These aboviral diseases have rapidly spread across globally in the last decade, and have often led to large-scale endemic outbreaks in tropical and sub-tropical countries.

While these viral diseases are transmitted to humans by infected Aedes mosquitoes, Zika and chickungunya viruses are genetically related.

There are no specific therapeutic drugs to treat or cure these diseases and intervention is limited to controlling the symptoms such as fever — something that Sun Pharma aims to change.

“Our agreement with NIV for developing drugs against Zika, Chikungunya and Dengue is part of our broader commitment for developing new and improved vaccines and drugs against arboviruses that are of significant health importance to India and rest of the world,” said Kirti Ganorkar, Executive VP & Head, Global Business Development, Sun Pharma.

Devendra Mourya, Director of NIV, said: ”Rapid spread of Zika virus across the world has added threat to the list of Aedes borne infections. Unfortunately, yet no effective antivirals and vaccines are available for these infections. Our agreement with Sun Pharma aims to find a solution to these unmet needs”

The Zika virus was first isolated in Uganda in 1947. Since the 1950s, it has been known to occur within a narrow equatorial belt from Africa to Asia. From 2007-2016, the virus spread eastward, across the Pacific Ocean to the Americas, leading to the 2015-2016 Zika virus epidemic. The virus was first detected in India in December 2016 in Ahmedabad, Gujarat. The infection, known as Zika fever or Zika virus disease, often causes no or only mild symptoms, similar to a very mild form of dengue fever. Zika can spread from a pregnant woman to her baby. This can result in microcephaly, severe brain malformations, and other birth defects. Zika infections in adults may result rarely in Guillain-Barre syndrome There is no specific treatment or vaccine available for this virus.

Chikungunya is an infection caused by the chikungunya virus, belonging to the family Togaviridae. The most common symptoms of chikungunya virus infection are fever and joint pain. Other symptoms may include headache, muscle pain, joint swelling, or rash. Outbreaks have occurred in countries in Africa, Asia, Europe, and the Indian and Pacific Oceans. While the disease typically occurs in Africa and Asia, outbreaks have been reported in Europe and the Americas since the 2000s. There is no vaccine to prevent or drug to treat chikungunya virus.

Dengue is a neglected mosquito-borne viral disease that is rapidly spreading globally. Dengue incidence has increased by more than 30-fold in the past 50 years. Currently, half of the global population lives under dengue threat; and an estimated 390 million infections occur worldwide every year with approx. 100 million cases of clinical disease and over 25,000 deaths. All four dengue virus serotypes are now endemic in India. Currently, there are no available antivirals, which presents a public health challenge in India and other parts of the world, including developed nations. There is no specific treatment other than supportive clinical care, which is extremely difficult in developing countries with poor resources.

Follow ULTRA.news
Royal Orchid Hotels inks marketing tie-up with UK’s Bespoke Hotels Royal Orchid Hotels said it had tied up with Bespoke Hotels of the UK to market each others' properties to their customers.Bespoke manages over 200 hots with 9,500 hotel rooms, 8,000 employees and £815 million of assets."Royal Orchid now has the ability to offer its gues...
Cyient ties up with US start-up to incorporate AI tech in power solution Mumbai-based IT services provider Cyient said it has signed an agreement to incorporate machine learning meter and voltage signature technology from US-based startup Elpis in its solutions for power utilities."Through this agreement, Cyient and Elpis will jointly pursue util...
Infosys to deliver private cloud solution based on Suse Linux and Openstack IT services provider Infosys said it now offers a private cloud solution built using SUSE Linux and Openstack.The solution will make use of Openstack cloud and datacenter solutions developed by Germany-based Micro Focus SUSE.Infosys and Micro Focus SUSE have jointly inve...
L&T Technology Services to co-develop solutions with Intel unit L&T Technology Services, the engineering services arm of the construction conglomerate, will co-develop industrial solutions with Intel subsidiary Wind River, which works in the emerging domain of Internet of Things.Under the partnership L&T Technology Services will "validat...
Godrej Properties, Nirmal to co-develop huge project in Thane West Mumbai-based real estate company Godrej Properties said it has signed a joint venture agreement with Nirmal Ventures, also based in Mumbai, for developing a residential project in Thane.The project, located on the Lal Bahadur Shastri (LBS) Marg, Thane West, will be developed...
Wipro opens Artificial Intelligence research facility in Israel University IT and outsourcing services provider Wipro said it will use students at Israel's largest university to jointly conduct research into artificial intelligence.The company inked an agreement with Tel Aviv University, Israel's largest institution of higher learning which is home ...
Sun Pharma selects Samsung to manufacture psoriasis drug Sun Pharma said it has inked a long-term agreement with Samsung BioLogics under which the Korean company will manufacture Tildrakizumab, a potential treatment for plaque psoriasis, for the Indian company.Plaque psoriasis is an autoimmune condition which results in patches of ...
Anil Ambani Group ties up with Thales for Rafale contracts Reliance Defence, the defence manufacturing arm of the Anil Ambani group, said it will form a joint venture in India with global defence manufacturer Thales to carry out some contracts related to the Rafale jet deal.The Indian company will hold 51% of the equity while the fo...
Jet Airways inks codeshare agreement with Aeromexico Jet Airways said it inked an agreement with Aeromexico, the flag carrier airline of Mexico, to explore codeshare arrangements and shared frequent flyer programs. As part of the arrangement, both carriers will code on each other’s services between India and Mexico via common ...
Baba Ramdev’s Patanjali expands Ruchi Soya tie-up, eyes 20,000 cr edible oil sales Patanjali Ayurved, the consumer products company headed by yoga exponent Baba Ramdev, has scaled up its agreement with Ruchi Soya, which has been facing financial stress due to high debt levels.Ruchi Soya said the two companies have agreed to expand their initial agreement --...
Aditya Birla´s fashion and retail unit ties up with UK luxury brand Ted Baker Aditya Birla Fashion and Retail Ltd said it entered into agreement with UK based fashion brand Ted Baker.Ted Baker London is a British luxury clothing retail company."We are happy to join hands with Ted Baker and build a strong presence for the brand with Indian consumers...
Lypsa Gems to sell via Gitanjali Group’s jewelsouk.com Lypsa Gems and Jewellery Ltd said it tied up with Jewelsouk.com to sell ‘Lypsa Atelier’ branded diamond-studded jewellery.“This tie-up is part of our E-commerce push. Lypsa Atelier is currently available on Flipkart, Snapdeal, Craftsvilla, Shopclues in addition to Jewelsouk.”...
Sun Pharma to get dengue vaccine technology from ICGEB Pharma major Sun Pharma said it tied up with research organization International Centre for Genetic Engineering and Biotechnology to develop vaccines for dengue.The vaccine is targeted against all the four serotypes of Dengue virus that cause disease in humans and is being de...
Bajaj Finance to provide auto loans to Baxi drivers Baxi, which operates commercial two wheelers, said it has partnered with Bajaj Finance Limited to finance salaried individuals who want to buy new bikes with the option to operate on a ride share basis.As part of the agreement, Bajaj Finance will provide attractive loans with...
US Govt agency to help disburse loans to Indian SMEs RBL Bank and NeoGrowth Credit Pvt will provide loans to small and medium enterprises in the Indian retail segment that are excluded from mainstream funding and financing with the help of a US government agency.The funding will be backed by the Overseas Private Investment ...
Lupin licenses taste-masking technology from Monosol for paediatric tablets Pharma Major Lupin Ltd. said its US subsidiary, Lupin Pharmaceutical Inc., has agreed to license technology from Monosol Rx to develop multiple paediatric-focused products.Lupin would develop the pediatric products utilizing MonoSol Rx’s proprietary PharmFilm drug delivery ...
Ruchi Soya to plant oil palm in 25,000 hectares in Arunachal Pradesh Agri and Food FMCG company Ruchi Soya Industries Ltd. said it signed an agreement with the Government of Arunachal Pradesh to boost palm oil production through development of quality palm plantations and human capacity building.With this agreement, Ruchi Soya Industries Limit...
Cadila to launch immunosuppressant drug in India Cadila Healthcare, a Ahmedabad headquartered pharmaceutical company owned by Zydus Group, said it has partnered with Switzerland-based global biopharmaceutical company Neovii to launch an drug to reduce the strength of the body's immune system in India.The drug named Grafalon...
Cognizant to help transform Future Group’s consumer business Cognizant said that it has entered into a partnership with Future Group, an Indian multi-brand retailer, to transform its consumer goods business, Future Consumer Limited (FCL), into a connected enterprise.“In an era where data, insights and supply chain intelligence are cruc...
L&T partners with Microsoft to set up “Green Campuses” L&T Technology Services, the information technology company of the L&T group, said it has partnered with Microsoft Corporation to offer a solution to lower energy bills and cost of maintenance.L&T Technology Service's Integrated Building Energy Management Syst...